Dysregulated and inappropriate CD8+ T cell activation can underpin pathology in autoimmune diseases such as type 1 diabetes (T1D) and systemic lupus erythematosus (SLE) [14]. This evidence concerns the gene CD8A and systemic lupus erythematosus.